Clinical Trial Update: Epidemiology of Atherosclerosis

View source ↗

Summary

This clinical trial update from NHLBI provides epidemiological insights on atherosclerosis, detailing current prevalence, risk factors, and population trends.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Cardiovascular Diseases | Status: COMPLETED